A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy
X Wang, P Wang, Z Zhao, Q Mao… - … advances in medical …, 2020 - journals.sagepub.com
Radiotherapy is a frequently utilized therapeutic modality in the treatment of esophageal
cancer (EC). Even though extensive studies are carried out in radiotherapy for EC, the …
cancer (EC). Even though extensive studies are carried out in radiotherapy for EC, the …
Advantages of salvage photodynamic therapy using talaporfin sodium for local failure after chemoradiotherapy or radiotherapy for esophageal cancer
T Minamide, Y Yoda, K Hori, K Shinmura, Y Oono… - Surgical …, 2020 - Springer
Background Photodynamic therapy (PDT) is a salvage treatment for local failure following
chemoradiotherapy (CRT) for esophageal cancer. This study aimed to evaluate the efficacy …
chemoradiotherapy (CRT) for esophageal cancer. This study aimed to evaluate the efficacy …
Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer
Y Nakatani, K Kato, H Shoji, S Iwasa, Y Honma… - International Journal of …, 2020 - Springer
Background The optimal radiation field of chemoradiation therapy (CRT) for stage I
esophageal squamous cell carcinoma (ESCC) is unknown. This retrospective study …
esophageal squamous cell carcinoma (ESCC) is unknown. This retrospective study …
[HTML][HTML] Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial …
X Chang, L Deng, W Ni, C Li, W Han, L Gao, S Wang… - BMC cancer, 2020 - Springer
Background Currently, adjuvant therapy is not recommended for patients with thoracic
esophageal squamous cell cancer (TESCC) after radical surgery, and a proportion of these …
esophageal squamous cell cancer (TESCC) after radical surgery, and a proportion of these …
[HTML][HTML] Outcomes of definitive chemoradiotherapy for stage iva (T4b vs. n4) esophageal squamous cell carcinoma based on the japanese classification system: A …
Y Wada, A Anbai, N Takagi, S Kumagai, E Okuyama… - Cancers, 2020 - mdpi.com
Simple Summary Definitive chemoradiotherapy is a standard treatment for stage IVa
esophageal cancer, although it is unclear whether T/N factors affect treatment outcomes and …
esophageal cancer, although it is unclear whether T/N factors affect treatment outcomes and …
[PDF][PDF] Outcomes of Definitive Chemoradiotherapy for Stage Iva (T4b Vs N4) Esophageal Cancer Based on the Japanese Classification System: A Retrospective …
Y Wada, A Anbai, N Takagi, S Kumagai, E Okuyama… - 2020 - scholar.archive.org
Abstract Background: Based on the Japanese classi cation of esophageal cancer, Stage IVa
involves locally advanced T4b disease and/or lymphatic spread (N4). Stage IVa disease is …
involves locally advanced T4b disease and/or lymphatic spread (N4). Stage IVa disease is …
Radiation Therapy for Esophageal Squamous Cell Carcinoma
Y Ito - … Squamous Cell Carcinoma: Diagnosis and Treatment, 2020 - Springer
Radiotherapy is indicated for the treatment of esophageal cancer both with curative intent
and with palliative intent. Concurrent chemoradiotherapy is the standard treatment for …
and with palliative intent. Concurrent chemoradiotherapy is the standard treatment for …
[PDF][PDF] Photodynamic Therapy for Esophageal Cancer
TIR Ishihara - 2020 - scholar.archive.org
Esophageal cancer is the eighth most common cancer and the sixth highest cause of cancer-
related death worldwide. 1 It consists of two main histological subtypes: esophageal …
related death worldwide. 1 It consists of two main histological subtypes: esophageal …
Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer
中谷行宏， ナカタニユキヒロ - 2020 - jair.repo.nii.ac.jp
Methods Patients had received 60 Gy CRT concurrently with 5-FU and cisplatin between
January 2000 and December 2012. The clinical target volume of IFI was limited to the …
January 2000 and December 2012. The clinical target volume of IFI was limited to the …